Accelerated Enrollment
Targeted Recruitment
Optimizing For Rare Populations: 1nHealth was activated to recruit patients with venous ulcers resulting from chronic venous insufficiency, a rare disease with a population of fewer than 600,000. In addition to being a smaller patient population, the screening process was complicated and the intervention was a procure.
Personalized Recruitment Strategies: In rare disease trials, strategic precision is essential due to smaller patient populations and unique disease characteristics. It’s crucial to identify the right participants, optimize outreach, and provide clear, empathetic communication to build trust. Effective A/B testing and patient support systems help overcome barriers to enrollment, ensuring a higher chance of success. By carefully crafting a tailored approach, clinical trials for rare diseases can thrive despite the challenges posed by these limited patient pools.
Streamlining The Patient Journey: For clinical trials in rare diseases, where each patient is essential, a seamless user experience helps reduce dropout rates and accelerates enrollment. Patients often face barriers like confusion over eligibility or complex logistics, so making the process as clear and efficient as possible encourages participation. Offering easy access to information, timely follow-ups, and straightforward onboarding ensures that patients stay engaged and committed, driving successful outcomes and advancing research for rare conditions.
Exceeding Enrollment Expectations: By the end of the study, we had optimized top-of-funnel recruitment ads to the point that month-over-month lead volume had increased by 144%. We finished the campaign strong, fully enrolling the study within 12 months after the previous recruitment vendor had failed to recruit even 20% of their target over the previous 12 months.
